BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14712934)

  • 21. Toward the quantitative prediction of T-cell epitopes: QSAR studies on peptides having affinity with the class I MHC molecular HLA-A*0201.
    Zhihua L; Yuzhang W; Bo Z; Bing N; Li W
    J Comput Biol; 2004; 11(4):683-94. PubMed ID: 15579238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell receptor/peptide/MHC molecular characterization and standardized pMHC contact sites in IMGT/3Dstructure-DB.
    Kaas Q; Lefranc MP
    In Silico Biol; 2005; 5(5-6):505-28. PubMed ID: 16268793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JenPep: a novel computational information resource for immunobiology and vaccinology.
    McSparron H; Blythe MJ; Zygouri C; Doytchinova IA; Flower DR
    J Chem Inf Comput Sci; 2003; 43(4):1276-87. PubMed ID: 12870921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of antifusion peptides with HIVgp41 from molecular dynamics simulations: quantitative correlation with experiment.
    Strockbine B; Rizzo RC
    Proteins; 2007 May; 67(3):630-42. PubMed ID: 17335007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor.
    Michielan L; Bacilieri M; Schiesaro A; Bolcato C; Pastorin G; Spalluto G; Cacciari B; Klotz KN; Kaseda C; Moro S
    J Chem Inf Model; 2008 Feb; 48(2):350-63. PubMed ID: 18215030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
    Schiewe AJ; Haworth IS
    J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JenPep: a database of quantitative functional peptide data for immunology.
    Blythe MJ; Doytchinova IA; Flower DR
    Bioinformatics; 2002 Mar; 18(3):434-9. PubMed ID: 11934742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validation.
    Desmet J; Meersseman G; Boutonnet N; Pletinckx J; De Clercq K; Debulpaep M; Braeckman T; Lasters I
    Proteins; 2005 Jan; 58(1):53-69. PubMed ID: 15526297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A structure-based, quantitative structure-activity relationship approach for predicting HLA-A*0201-restricted cytotoxic T lymphocyte epitopes.
    Zhou P; Tian F; Li Z
    Chem Biol Drug Des; 2007 Jan; 69(1):56-67. PubMed ID: 17313458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QSAR method for prediction of protein-peptide binding affinity: application to MHC class I molecule HLA-A*0201.
    Zhao C; Zhang H; Luan F; Zhang R; Liu M; Hu Z; Fan B
    J Mol Graph Model; 2007 Jul; 26(1):246-54. PubMed ID: 17275373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex.
    Kosmopoulou A; Vlassi M; Stavrakoudis A; Sakarellos C; Sakarellos-Daitsiotis M
    J Comput Chem; 2006 Jul; 27(9):1033-44. PubMed ID: 16639700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein.
    Koehler NK; Yang CY; Varady J; Lu Y; Wu XW; Liu M; Yin D; Bartels M; Xu BY; Roller PP; Long YQ; Li P; Kattah M; Cohn ML; Moran K; Tilley E; Richert JR; Wang S
    J Med Chem; 2004 Oct; 47(21):4989-97. PubMed ID: 15456243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational studies of COX-2 inhibitors: 3D-QSAR and docking.
    Kim HJ; Chae CH; Yi KY; Park KL; Yoo SE
    Bioorg Med Chem; 2004 Apr; 12(7):1629-41. PubMed ID: 15028256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurate prediction of stability changes in protein mutants by combining machine learning with structure based computational mutagenesis.
    Masso M; Vaisman II
    Bioinformatics; 2008 Sep; 24(18):2002-9. PubMed ID: 18632749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular dynamics and structure-based drug design for predicting non-natural nonapeptide binding to a class I MHC protein.
    Scapozza L; Rognan D; Folkers G; Daser A
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):541-9. PubMed ID: 15299842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational methods for prediction of T-cell epitopes--a framework for modelling, testing, and applications.
    Brusic V; Bajic VB; Petrovsky N
    Methods; 2004 Dec; 34(4):436-43. PubMed ID: 15542369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atom-based 3D-chiral quadratic indices. Part 2: prediction of the corticosteroid-binding globulinbinding affinity of the 31 benchmark steroids data set.
    Castillo-Garit JA; Marrero-Ponce Y; Torrens F
    Bioorg Med Chem; 2006 Apr; 14(7):2398-408. PubMed ID: 16325409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting class I major histocompatibility complex (MHC) binders using multivariate statistics: comparison of discriminant analysis and multiple linear regression.
    Doytchinova IA; Flower DR
    J Chem Inf Model; 2007; 47(1):234-8. PubMed ID: 17238269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting peptide binding to MHC pockets via molecular modeling, implicit solvation, and global optimization.
    Schafroth HD; Floudas CA
    Proteins; 2004 Feb; 54(3):534-56. PubMed ID: 14748001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling ligand-receptor interaction for some MHC class II HLA-DR4 peptide mimetic inhibitors using several molecular docking and 3D QSAR techniques.
    Wei HY; Tsai KC; Lin TH
    J Chem Inf Model; 2005; 45(5):1343-51. PubMed ID: 16180911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.